c

Nice | Ticagrelor for the treatment of acute coronary syndrome ACS

4th November 2011 by Louise Hudman

Ticagrelor is a PO drug which inhibits platelet aggregation. In combination with aspirin it is more effective than clopidogrel + aspirin at reducing the endpoint of MI or death from vascular events.

It will be started by secondary care and continued by cardiologists, so we shouldn’t really have to initiate it.

It will be started in patients who’ve had a STEMI where primary percutaneous coronary intervention (PCI) is considered and also in patients with a NSTEMI who have certain other risk factors.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I became a GP locum in February 2023, having been a salaried GP for 10 years, and I've used LocumDeck from the start. LocumDeck has made the transition to locuming very easy which is why I only have the highest praise for your platform and team, who are always very supportive.
"

Dr Emma Andrews, GP locum, Burton-on-Trent

See the full list of features within our NASGP membership plans

Membership